JPS5040376A - - Google Patents

Info

Publication number
JPS5040376A
JPS5040376A JP49058692A JP5869274A JPS5040376A JP S5040376 A JPS5040376 A JP S5040376A JP 49058692 A JP49058692 A JP 49058692A JP 5869274 A JP5869274 A JP 5869274A JP S5040376 A JPS5040376 A JP S5040376A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP49058692A
Other languages
Japanese (ja)
Other versions
JPS6132019B2 (cg-RX-API-DMAC10.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5040376A publication Critical patent/JPS5040376A/ja
Publication of JPS6132019B2 publication Critical patent/JPS6132019B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP49058692A 1973-05-24 1974-05-24 Expired JPS6132019B2 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2491573A GB1455296A (en) 1973-05-24 1973-05-24 Veterinary treatment

Publications (2)

Publication Number Publication Date
JPS5040376A true JPS5040376A (cg-RX-API-DMAC10.html) 1975-04-14
JPS6132019B2 JPS6132019B2 (cg-RX-API-DMAC10.html) 1986-07-24

Family

ID=10219274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49058692A Expired JPS6132019B2 (cg-RX-API-DMAC10.html) 1973-05-24 1974-05-24

Country Status (15)

Country Link
US (1) US3912806A (cg-RX-API-DMAC10.html)
JP (1) JPS6132019B2 (cg-RX-API-DMAC10.html)
BE (1) BE815295A (cg-RX-API-DMAC10.html)
CA (1) CA1045034A (cg-RX-API-DMAC10.html)
DE (1) DE2424101A1 (cg-RX-API-DMAC10.html)
DK (1) DK281074A (cg-RX-API-DMAC10.html)
ES (1) ES426605A1 (cg-RX-API-DMAC10.html)
FI (1) FI58434C (cg-RX-API-DMAC10.html)
FR (1) FR2230339B1 (cg-RX-API-DMAC10.html)
GB (1) GB1455296A (cg-RX-API-DMAC10.html)
IE (1) IE39244B1 (cg-RX-API-DMAC10.html)
NL (1) NL7406951A (cg-RX-API-DMAC10.html)
NO (1) NO142735C (cg-RX-API-DMAC10.html)
SE (1) SE420460B (cg-RX-API-DMAC10.html)
ZA (1) ZA742938B (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01153625A (ja) * 1986-12-10 1989-06-15 Beecham Group Plc 動物の治療用製剤

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1547164A (en) * 1975-08-14 1979-06-06 Beecham Group Ltd Veterinary compositions
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
EP0076068A3 (en) * 1981-09-25 1985-05-15 Beecham Group Plc Intramammary veterinary compositions and method for their use
GB2119649B (en) * 1982-05-12 1986-02-12 Beecham Group Plc Ophthalmic cloxacillin compositions
US4793993A (en) * 1987-07-06 1988-12-27 Chesebrough-Pond's Inc. Crosslinking of hair thiols
AU5574294A (en) * 1992-12-08 1994-07-04 Bimeda Research & Development Limited Aqueous antibiotic composition for veterinary use
DK0971690T4 (en) * 1996-12-18 2015-07-13 Bimeda Res & Dev Ltd Anti-infective intramammary veterinary composition.
NZ531618A (en) * 2001-09-10 2005-03-24 Bimeda Res & Dev Ltd A bio-security system
US20040197422A1 (en) * 2002-12-20 2004-10-07 Pfizer Inc Veterinary compositions for treating mastitis
GB0229642D0 (en) † 2002-12-20 2003-01-22 Pfizer Ltd Veterinary compositions for treating mastitis
EP1718237A1 (en) * 2004-02-02 2006-11-08 Bimeda Research And Development Limited A method and device for treating a teat canal of an animal
CA2824121C (en) 2004-02-02 2016-11-22 Zoetis Broomhill Ip Limited Method and device for treating a teat canal of an animal
EP2079477B1 (en) * 2006-10-10 2017-07-26 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
KR20120005497A (ko) 2009-04-08 2012-01-16 위스콘신 얼럼나이 리서어치 화운데이션 유방내 유두 밀봉 제제 및 이를 사용하여 숙성된 치즈에서 시각적 결함을 감소 또는 제거시키는 방법
US9737047B2 (en) 2011-03-22 2017-08-22 Ccd Holdings Llc Method for the treatment, control, minimization, and prevention of bovine mastitis
US8757092B2 (en) 2011-03-22 2014-06-24 Eco-Composites Llc Animal bedding and associated method for preparing the same
CN104188964B (zh) * 2014-09-11 2016-07-13 保定冀中药业有限公司 一种长效苄星氯唑西林乳房注入剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US3328256A (en) * 1963-05-27 1967-06-27 William E Gaunt Spherical beads and their production
US3576760A (en) * 1969-06-13 1971-04-27 Nat Patent Dev Corp Water soluble entrapping

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01153625A (ja) * 1986-12-10 1989-06-15 Beecham Group Plc 動物の治療用製剤

Also Published As

Publication number Publication date
DK281074A (cg-RX-API-DMAC10.html) 1975-01-20
GB1455296A (en) 1976-11-10
SE420460B (sv) 1981-10-12
IE39244B1 (en) 1978-08-30
JPS6132019B2 (cg-RX-API-DMAC10.html) 1986-07-24
FI58434B (fi) 1980-10-31
FR2230339B1 (cg-RX-API-DMAC10.html) 1977-11-04
NO142735C (no) 1980-10-08
CA1045034A (en) 1978-12-26
BE815295A (fr) 1974-11-20
NL7406951A (cg-RX-API-DMAC10.html) 1974-11-26
ES426605A1 (es) 1977-03-01
FR2230339A1 (cg-RX-API-DMAC10.html) 1974-12-20
IE39244L (en) 1974-11-24
AU6905774A (en) 1975-11-20
NO741886L (no) 1974-11-26
DE2424101A1 (de) 1974-12-12
FI58434C (fi) 1981-02-10
ZA742938B (en) 1975-05-28
NO142735B (no) 1980-06-30
US3912806A (en) 1975-10-14
FI158274A7 (cg-RX-API-DMAC10.html) 1974-11-25

Similar Documents

Publication Publication Date Title
AR201758A1 (cg-RX-API-DMAC10.html)
AU476761B2 (cg-RX-API-DMAC10.html)
AR201235Q (cg-RX-API-DMAC10.html)
AR201231Q (cg-RX-API-DMAC10.html)
AU474593B2 (cg-RX-API-DMAC10.html)
AU474511B2 (cg-RX-API-DMAC10.html)
AU474838B2 (cg-RX-API-DMAC10.html)
FR2230339B1 (cg-RX-API-DMAC10.html)
AU465453B2 (cg-RX-API-DMAC10.html)
AU450229B2 (cg-RX-API-DMAC10.html)
AU476714B2 (cg-RX-API-DMAC10.html)
AR201229Q (cg-RX-API-DMAC10.html)
AU472848B2 (cg-RX-API-DMAC10.html)
AU476696B2 (cg-RX-API-DMAC10.html)
AR199451A1 (cg-RX-API-DMAC10.html)
AU466283B2 (cg-RX-API-DMAC10.html)
AU476873B1 (cg-RX-API-DMAC10.html)
AR193950A1 (cg-RX-API-DMAC10.html)
AR200256A1 (cg-RX-API-DMAC10.html)
AR195948A1 (cg-RX-API-DMAC10.html)
AU447540B2 (cg-RX-API-DMAC10.html)
AU477824B2 (cg-RX-API-DMAC10.html)
AR210729A1 (cg-RX-API-DMAC10.html)
AR200885A1 (cg-RX-API-DMAC10.html)
AR196382A1 (cg-RX-API-DMAC10.html)